JNJ’s ICOTYDE, a new oral pill for moderate to severe plaque psoriasis was approved by FDA.
3:00
JNJ’s ICOTYDE, a new oral pill for moderate to severe plaque psoriasis was approved by FDA.
1.3K views3 months ago
YouTubeBiotechTV
See more
Static thumbnail place holder